Gallagher Fiduciary Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$411K Sell
4,525
-575
-11% -$52.5K 0.01% 241
2026
Q1
$524K Buy
5,100
+79
+2% +$8.92K 0.02% 149
2025
Q4
$629K Buy
5,021
+235
+5% +$29.9K 0.02% 149
2025
Q3
$641K Buy
4,786
+40
+0.8% +$5.25K 0.02% 122
2025
Q2
$646K Buy
4,746
+250
+6% +$33K 0.03% 138
2025
Q1
$596K Buy
4,496
+35
+0.8% +$4.45K 0.02% 137
2024
Q4
$505K Buy
4,461
+942
+27% +$109K 0.1% 141
2024
Q3
$401K Buy
3,519
+737
+26% +$80.8K 0.08% 151
2024
Q2
$289K Buy
2,782
+1,022
+58% +$108K 0.06% 164
2024
Q1
$200K Buy
+1,760
New +$202K 0.01% 191

Other funds holding ABT

Gallagher Fiduciary Advisors's ABT Position: Q2 2026 in Review

Gallagher Fiduciary Advisors reduced its Abbott (ABT) stake by 11% in Q2 2026, selling an estimated $52.5K and leaving 4,525 shares worth $411K. The position accounts for 0.01% of the portfolio, ranked #241.

Gallagher Fiduciary Advisors first reported a position in ABT in Q1 2024 and has held it in 10 quarters since. The position peaked at $646K in Q2 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Gallagher Fiduciary Advisors held 4,525 shares of Abbott worth $411K as of Q2 2026.
  • Gallagher Fiduciary Advisors sold 575 Abbott shares in Q2 2026, an estimated $52.5K.
  • Abbott made up 0.01% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #241 holding.
  • Gallagher Fiduciary Advisors first reported a position in Abbott in Q1 2024 and has held it in 10 quarters since.
  • Gallagher Fiduciary Advisors's Abbott position peaked at $646K in Q2 2025.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.